NCT06960174

Brief Summary

Rationale: Preoperative planning for both partial and radical nephrectomies using conventional CT imaging can be challenging due to complex renal anatomy and vascularization. 3D models in virtual reality (VR) may enhance anatomical understanding and improve preoperative planning. This study aims to prospectively evaluate the clinical impact of the use of 3D models in VR in the preoperative planning of partial and radical nephrectomies. Objective: The primary objective is to assess the impact of VR on preoperative planning and thereby on the agreement between the preoperative plan and the performed surgery in renal surgery (both partial and radical nephrectomies). The secondary objectives focus on the urologist's understanding of the anatomy and how the intraoperative and postoperative outcomes are influenced by the use of VR in the preoperative planning. Study design: The Virtual Renality study is a single-center randomized clinical trial conducted at the St. Antonius Hospital in Nieuwegein. Study population: The study population will consist of adult patients (18+) with a suspected RCC who are indicated for (partial) nephrectomy at St. Antonius Hospital Nieuwegein. Intervention: For the intervention group, the urologist will review a 3D virtual model of the renal anatomy in addition to the original CT scan during preoperative planning. For the control group, only the CT scan will be used for preoperative planning, according to the current standard of care. Main study parameters/endpoints: The primary study endpoint is the surgical concordance score, which describes the concordance between the actual performed surgery and the preoperatively determined surgical plan. Nature and extent of the burden and risks associated with participation, benefit, and group relatedness: Participation in this study will not require any additional physical examinations, blood samples, hospital visits, or questionnaires beyond standard clinical care. The only difference for participants in the intervention group is that a 3D model will be created from the existing CT scan and reviewed in VR during preoperative planning by the urologist.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2025

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 18, 2025

Completed
19 days until next milestone

First Posted

Study publicly available on registry

May 7, 2025

Completed
26 days until next milestone

Study Start

First participant enrolled

June 2, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2026

Completed
Last Updated

May 7, 2025

Status Verified

April 1, 2025

Enrollment Period

7 months

First QC Date

April 18, 2025

Last Update Submit

April 28, 2025

Conditions

Keywords

Renal Cell CarcinomaPartial nephrectomyRadical nephrectomyPreoperative planning3D virtual modelVirtual Reality

Outcome Measures

Primary Outcomes (1)

  • Concordance score between actual performed surgery and surgical plan

    To assess whether the surgery is performed according to the preoperative plan, a questionnaire regarding the expected surgical steps will be completed during the preoperative planning. Postoperatively, the data will be collected from the surgical notes. The postoperative data will be compared with the preoperatively filled questionnaire and this will result in a concordance score between the actual performed surgery and the preoperatively determined surgical plan. This score of concordance will be the primary study endpoint

    during preoperative planning (approximately 3 days before surgery) and immediately after surgery

Secondary Outcomes (16)

  • Intra-operative parameters: method of clamping

    Perioperative

  • Intraoperative parameters: blood loss

    Perioperative

  • Intraoperative parameters: clamping time

    Perioperative

  • Intraoperative parameters: opening of collecting system

    Perioperative

  • Intraoperative parameters: duration of surgery

    Perioperative

  • +11 more secondary outcomes

Other Outcomes (12)

  • Demographic data - age

    before surgery

  • Demographic data - gender

    before surgery

  • Medical data - BMI

    before surgery

  • +9 more other outcomes

Study Arms (2)

Preoperative planning based on CT

NO INTERVENTION

For the control group the preoperative planning will be according to the current standard of care using only the CT scan.

Preoperative planning based on CT + VR

EXPERIMENTAL

For the intervention group, the urologist will review a 3D virtual model of the renal anatomy in addition to the CT scan during preoperative planning

Device: Virtual reality

Interventions

If the participant is assigned to the intervention group a 3D virtual model will be constructed. For the intervention group the CT + VR will be reviewed during preoperative planning.

Preoperative planning based on CT + VR

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Suspected RCC and candidate for (partial) nephrectomy
  • Signed informed consent

You may not qualify if:

  • Patients who are not approved to undergo surgery (due to comorbidities or their overall health condition)
  • Patients who are unable to give informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Carcinoma, Renal CellKidney Neoplasms

Condition Hierarchy (Ancestors)

AdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsUrologic NeoplasmsUrogenital NeoplasmsNeoplasms by SiteFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesKidney DiseasesUrologic DiseasesMale Urogenital Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 18, 2025

First Posted

May 7, 2025

Study Start

June 2, 2025

Primary Completion

December 31, 2025

Study Completion

January 31, 2026

Last Updated

May 7, 2025

Record last verified: 2025-04